This is a statement made at the 74th session of the World Health Assembly on Agenda item 17: Strengthening WHO’s global emergency preparedness and response by the World Heart Federation, Framework Convention Alliance, International Alliance of Patients’ Organizations, International Atherosclerosis Society, International Diabetes Federation, International Society of Hypertension, International Society of Nephrology, World Hypertension League, […]
This is a statement made at the 74th session of the World Health Assembly on Agenda item 13.3: Political declaration of the third high-level meeting of the General Assembly on the prevention and control of non-communicable diseases by the International Diabetes Federation, International Alliance of Patients’ Organisations, International Association for Dental Research, International Atherosclerosis Society, […]
This is a statement made at the 74th session of the World Health Assembly on Agenda item 13.2: Political declaration of the third high-level meeting of the General Assembly on the prevention and control of non-communicable diseases by the World Dental Federation and the International Association for Dental Research supported by the World Heart Federation, […]
In the wake of World Hypertension Day, we are delighted to announce our partnership with LoSalt®, the UK’s leading reduced sodium salt. With a shared purpose of reducing incidence of hypertension, the partnership has been formed in a bid to raise consumer awareness, particularly in relation to reducing sodium consumption. Hypertension, commonly known as high […]
Our film The Beat of Change: Rheumatic Heart Disease in Mozambique, which tells the story of a young mother struggling with the consequences of RHD, has been selected as the winner of the special prize for Health Equity at the World Health Organization (WHO) Health for All Film Festival. “This is a wonderful film, it’s […]
A first of its kind study about the cost and benefit of investment in the prevention and management of Rheumatic Heart Disease (RHD) in the African Union was published today in the Lancet Global Health. The main finding is that mortality can be reduced by 30% over the next decade by investing USD 100 million […]
Interview on “The Investment Case for the Prevention and Management of Rheumatic Heart Disease in the African Union 2021-2030: a Modelling Study” with co-author Professor Karen Sliwa, Director of the Hatter Institute for Cardiovascular Research in Africa at the University of Cape Town and Past President of the World Heart Federation (WHF). WHF: What […]
Interview on “The Investment Case for the Prevention and Management of Rheumatic Heart Disease in the African Union 2021-2030: A Modelling Study” with co-author Gene Bukhman, cardiologist at Brigham and Women’s Hospital (BWH), Assistant Professor of Medicine and Assistant Professor of Global Health and Social Medicine at Harvard Medical School. WHF: What was the […]
WHF position statement on COVID-19 vaccination underscores urgency and priority With at least 200 countries battling the COVID-19 pandemic, 3 million deaths and counting, plus worrying virus mutations, this month’s World Health Day took on special meaning. More than 550 million vaccine doses have been administered– good news, yes, but just how good will be […]
First discovered more than 100 years ago, Chagas disease continues to affect more than six million people worldwide and is one of the most prevalent public health problems in Latin America and, increasingly, on a global scale. In the last decades, migratory patterns have spread the disease to areas where it was previously unknown, including […]
Angina affects more than 100 million people globally.[1] Angina has a negative impact on quality of life and leads to a 3-fold higher risk of disability,[2]5-fold higher risk of job loss,5 and 4-fold higher risk of depression.[3] 43% of angina patients remain underrecognized.[4] 60% of angina patients are not receiving an optimal therapy.[5] The Covid-19 […]